Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HD6610 Granule for Oxaliplatin-Induced Peripheral Neuropathy
NCT02590367Phase 3Unknown
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Start
- Aug 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of HD6610 in peripheral neuropathy, sponsored by Jiangsu Provincial Hospital of Traditional Chinese Medicine. Status: unknown.
02
Drugs
HD6610
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on NCT02590367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590367.